The report “Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027” The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.
Gather more insights about the market drivers, restrains and growth of the Infectious Disease Diagnostics Market
The global prevalence of infectious diseases and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements are factors supporting the growth of this market. Growth opportunities in growing economies provide lucrative opportunities for the players operating in the infectious disease diagnostics market.
The reagents, kits, and consumables segment accounted for the largest share of the infectious disease diagnostics market, by product & service segment
Based on product & service, the infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services. the reagents, kits, and consumables segment accounted for the largest share of this market. The requirement of reagents, kits, and consumables in large numbers compared to instruments is the main factor contributing to the large share of this segment.
POC testing segment to register the highest CAGR during the forecast period
Based on the type of testing, the infectious disease diagnostics market has been segmented into laboratory testing and POC testing. In 2021, the POC testing segment accounted for the highest CAGR. This can be attributed to the need to closely monitor patient conditions and advantages such as faster diagnosis.
The COVID-19 segment accounted for the largest share of the infectious disease diagnostics market, by disease type segment
Based on disease type, the infectious disease diagnostics market is segmented into COVID-19, HIV, HAIs, hepatitis, CT, NG, HPV, Tuberculosis, influenza, syphilis, mosquito-borne diseases and other infectious diseases.
The diagnostic laboratories segment accounted for the largest share of the infectious disease diagnostics market, by end user segment
Based on end user, the infectious disease diagnostics market has been segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users. diagnostic laboratories accounted for the largest share of the infectious disease diagnostics market.
North America is the largest regional market for infectious disease diagnostics market
The infectious disease diagnostics market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the infectious disease diagnostics market. The large share of this region can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.
Some key players in the infectious disease diagnostics market (2022- 2027)
- Abbott Laboratories (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Thermo Fisher Scientific Inc. (US)
- Siemens Healthineers AG (Germany)
- bioMérieux SA (France)
This report categorizes the infectious disease diagnostics market into the following segments and subsegments:
By Product
- Reagents, Kits, and Consumables
- Instruments
- Software & Services
By Type of Testing
- Laboratory Testing
- POC Testing
By Technology
- Immunodiagnostics
- Clinical Microbiology
- PCR
- INAAT
- DNA Sequencing & NGS
- DNA Microarray
- Other technologies
By Disease Type
- COVID-19
- HIV
- Hospital-acquired Infections
- Hepatitis
- Chlamydia Trachomatis
- Neisseria Gonorrhea
- HPV
- Tuberculosis
- Influenza
- Syphilis
- Mosquito-borne Diseases
- Other Infectious Diseases
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
- Academic Research Institutes
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Market Share Insights
- In November 2022, Roche Diagnostics Launched cobas 5800 system.
- Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.
- Abbott Laboratories launched the ID NOW COVID-19 Test.
Order a free sample PDF of the Infectious Disease Diagnostics Market Intelligence Study, published by MarketsandMarkets
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
